Bevacizumab in the therapy for refractory metastatic colorectal cancer

Mary F. Mulcahy

Research output: Contribution to journal › Review article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Bevacizumab in the therapy for refractory metastatic colorectal cancer'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

INIS

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology